ACADIA Pharmaceuticals, Inc. (ACAD)
21.32
+0.37
(+1.77%)
USD |
NASDAQ |
May 21, 16:00
21.32
0.00 (0.00%)
After-Hours: 18:39
ACADIA Pharmaceuticals Shareholders Equity (Quarterly) : 1.248B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 704.85M |
| Madrigal Pharmaceuticals, Inc. | 543.45M |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| MannKind Corp. | -59.20M |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.605B |
| Total Liabilities (Quarterly) | 357.16M |
| Debt to Equity Ratio | 0.0407 |
| Current Ratio | 3.587 |
| Net Debt Paydown Yield | 0.01% |